118 related articles for article (PubMed ID: 35770414)
1. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
Yang MH; Wang YS; Shi XQ; Zhao XW; Li B
Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414
[TBL] [Abstract][Full Text] [Related]
2. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
Zheng JC; Chang KJ; Jin YX; Zhao XW; Li B; Yang MH
Med Sci Monit; 2019 Mar; 25():2228-2237. PubMed ID: 30913205
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
4. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
5. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
6. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Yang MH; Chang KJ; Li B; Chen WS
Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
[TBL] [Abstract][Full Text] [Related]
8. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH
Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217
[TBL] [Abstract][Full Text] [Related]
9. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
Yang MH; Li B; Chang KJ
Mol Biol Rep; 2022 Mar; 49(3):2245-2253. PubMed ID: 35028858
[TBL] [Abstract][Full Text] [Related]
10. The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.
Minami T; Jiang S; Schadler K; Suehiro J; Osawa T; Oike Y; Miura M; Naito M; Kodama T; Ryeom S
Cell Rep; 2013 Aug; 4(4):709-23. PubMed ID: 23954784
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.
Baggott RR; Alfranca A; López-Maderuelo D; Mohamed TM; Escolano A; Oller J; Ornes BC; Kurusamy S; Rowther FB; Brown JE; Oceandy D; Cartwright EJ; Wang W; Gómez-del Arco P; Martínez-Martínez S; Neyses L; Redondo JM; Armesilla AL
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2310-20. PubMed ID: 25147342
[TBL] [Abstract][Full Text] [Related]
12. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway.
Cano E; Canellada A; Minami T; Iglesias T; Redondo JM
J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916
[TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer.
Zhao X; Wang Q; Yang S; Chen C; Li X; Liu J; Zou Z; Cai D
Eur J Pharmacol; 2016 Jun; 781():60-8. PubMed ID: 27041643
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F
Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125
[TBL] [Abstract][Full Text] [Related]
17. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.
Lee MY; Garvey SM; Baras AS; Lemmon JA; Gomez MF; Schoppee Bortz PD; Daum G; LeBoeuf RC; Wamhoff BR
Hum Mol Genet; 2010 Feb; 19(3):468-79. PubMed ID: 19926569
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis.
Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW
Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
